Clostridioides difficile infection (CDI) is a healthcare-associated infection with significant
mortality, morbidity, and cost. Despite efforts by healthcare providers to adhere to infection …

In recent years, the increasing incidence of Clostridioides difficile infection (CDI) has posed
significant challenges to the medical community. The use of fecal microbiota transplants …

Background Clostridioides difficile infection (CDI) remains the leading cause of healthcare-
associated diarrhoea, despite existing guidelines for infection control measures and …

Background: Clostridioides difficile (C. difficile) is a spore-forming bacterial species that
ubiquitously exists in the environment. Colonization by C. difficile is highly prevalent in …

Fulminant Clostridioides difficile infection (FCDI) encompasses 3 to 5% of all CDI cases with
associated mortality rates between 30 and 40%. Major treatment modalities include surgery …

Purpose of review Clostridiodes difficile infection (CDI) has unique challenges for diagnosis
and treatment in pediatrics. Though new antibiotics and biologics are being approved or …

Clostridioides difficile is one of the most important causes of healthcare-associated diarrhea.
The high incidence and recurrence rates of C. difficile infection, as well as its associated …

Gastroenterology Volume 15 outline bile acids as a key metabolite of the gut microbiome
and review the association of changes between bile acid composition and CDI. Alterations …

Background: Clostridioides difficile infection (CDI) is a common nosocomial infection. Risk
factors for developing CDI include prior hospitalization, being older than 65 years old …

Background: Clostridioides difficile infection (CDI) is a major source of morbidity and
mortality. Even after recovery, recurrent CDI (rCDI) occurs frequently, and concomitant …